    <SEC-DOCUMENT>0000950170-25-058833-index.html : 20250425
    <SEC-HEADER>0000950170-25-058833.hdr.sgml : 20250425
    <ACCEPTANCE-DATETIME>20250425165406
    ACCESSION NUMBER:		0000950170-25-058833
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20241231
    FILED AS OF DATE:		20250425
    DATE AS OF CHANGE:		20250425
    EFFECTIVENESS DATE:		20250425

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			ACADIA PHARMACEUTICALS INC
    		CENTRAL INDEX KEY:			0001070494
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				061376651
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	000-50768
    		FILM NUMBER:		25874976

    	BUSINESS ADDRESS:
    		STREET 1:		12830 EL CAMINO REAL
    		STREET 2:		SUITE 400
    		CITY:			SAN DIEGO
    		STATE:			CA
    		ZIP:			92130
    		BUSINESS PHONE:		858-558-2871

    	MAIL ADDRESS:
    		STREET 1:		12830 EL CAMINO REAL
    		STREET 2:		SUITE 400
    		CITY:			SAN DIEGO
    		STATE:			CA
    		ZIP:			92130
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>acad_2024_annual_report.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: acad_2024_annual_report.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>